A detailed history of Hemington Wealth Management transactions in Abbott Laboratories stock. As of the latest transaction made, Hemington Wealth Management holds 1,971 shares of ABT stock, worth $201,692. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,971
Previous 2,301 14.34%
Holding current value
$201,692
Previous $253,000 11.07%
% of portfolio
0.08%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$109.52 - $120.96 $36,141 - $39,916
-330 Reduced 14.34%
1,971 $225,000
Q3 2023

Oct 20, 2023

SELL
$95.53 - $114.62 $27,034 - $32,437
-283 Reduced 10.95%
2,301 $222,000
Q2 2023

Aug 04, 2023

SELL
$100.78 - $112.29 $19,248 - $21,447
-191 Reduced 6.88%
2,584 $281,000
Q1 2023

May 05, 2023

SELL
$96.86 - $114.01 $5,908 - $6,954
-61 Reduced 2.15%
2,775 $281,000
Q4 2022

Jan 30, 2023

SELL
$95.06 - $111.52 $5,608 - $6,579
-59 Reduced 2.04%
2,836 $311,000
Q3 2022

Oct 31, 2022

BUY
$96.76 - $112.03 $16,062 - $18,596
166 Added 6.08%
2,895 $280,000
Q2 2022

Jul 22, 2022

BUY
$102.07 - $123.37 $3,878 - $4,688
38 Added 1.41%
2,729 $297,000
Q1 2022

May 04, 2022

SELL
$114.02 - $139.04 $62,140 - $75,776
-545 Reduced 16.84%
2,691 $319,000
Q4 2021

Jan 13, 2022

BUY
$115.53 - $141.46 $110,562 - $135,377
957 Added 41.99%
3,236 $354,000
Q3 2021

Oct 06, 2021

BUY
$116.66 - $129.06 $3,149 - $3,484
27 Added 1.2%
2,279 $269,000
Q2 2021

Jul 09, 2021

SELL
$105.79 - $124.53 $11,425 - $13,449
-108 Reduced 4.58%
2,252 $261,000
Q1 2021

Apr 12, 2021

SELL
$108.84 - $128.23 $95,343 - $112,329
-876 Reduced 27.07%
2,360 $283,000
Q4 2020

Feb 01, 2021

BUY
$105.0 - $114.42 $339,780 - $370,263
3,236 New
3,236 $354,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Hemington Wealth Management Portfolio

Follow Hemington Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemington Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Hemington Wealth Management with notifications on news.